Solving Key Challenges in Industrial Bioprocessing
Erik Vaessen, PhD, Executive Director, Life Sciences at FUJIFILM Irvine Scientific, addresses the current challenges in the Bioprocessing industry in a recent interview with Lab Manager Magazine, an industry-leading publication explicitly dedicated to all aspects of running a lab.
In the article, Vaessen emphasizes that as advancements and growth continue in protein therapeutic development, the new and rapidly growing field of advanced therapy medicinal product (ATMP) discovery presents unique challenges. When developing a bioprocess for ATMPs an unprecedented number of variables must be monitored and optimized. There is more to consider than optimizing cell culture media.
Also, Vaessen highlights the use of new technologies to advance bioprocessing including process analytical technology (PAT), artificial intelligence (AI), and machine learning (ML) as critical tools for optimizing production and product development to support a more efficient future. Adopting these technological advancements shorten process development time, lead to faster market entry, and potentially reduce costs, making therapies more accessible.
Vaessen also provides insights into facing key challenges brought about by COVID-19 and how partnering with the right supplier is critical to meet the rapidly changing demands affecting speed to market, scaling, logistics, and safety.
For more insights into effective ways to solve key challenges in industrial bioprocessing, read the full article.